Giles Wilson Acquires 222 Shares of Dr. Martens plc (LON:DOCS) Stock

Dr. Martens plc (LON:DOCS) insider Giles Wilson bought 222 shares of the business’s stock in a transaction dated Monday, January 13th. The stock was bought at an average price of GBX 68 ($0.83) per share, for a total transaction of £150.96 ($184.30).

Giles Wilson also recently made the following trade(s):

• On Monday, November 11th, Giles Wilson bought 263 shares of Dr. Martens stock. The stock was bought at an average price of GBX 57 ($0.70) per share, for a total transaction of £149.91 ($183.02).

Dr. Martens Stock Performance

DOCS traded up GBX 2.30 ($0.03) on Wednesday, hitting GBX 67.90 ($0.83). 980,791 shares of the company’s stock were exchanged, compared to its average volume of 2,871,344. The firm has a market cap of £653.01 million, a PE ratio of 970.00, a P/E/G ratio of 6.40 and a beta of 0.11. Dr. Martens plc has a twelve month low of GBX 49.32 ($0.60) and a twelve month high of GBX 100 ($1.22). The stock has a fifty day moving average of GBX 67.32 and a two-hundred day moving average of GBX 65.77. The company has a current ratio of 2.85, a quick ratio of 1.13 and a debt-to-equity ratio of 129.55.

Dr. Martens Cuts Dividend

The company also recently declared a dividend, which will be paid on Tuesday, April 8th. Shareholders of record on Thursday, March 6th will be paid a GBX 0.85 ($0.01) dividend. The ex-dividend date is Thursday, March 6th. This represents a dividend yield of 1.47%. Dr. Martens’s payout ratio is currently 4,285.71%.

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking
for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical
movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage
and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of
empowerment and their own individual attitude.

The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and
is a constituent of the FTSE 250 index.